Evidence map›Paper›PMID 30373647›Full record

ReviewCritical care (London, England)2018

Ascorbic acid, corticosteroids, and thiamine in sepsis: a review of the biologic rationale and the present state of clinical evaluation.

Ari Moskowitz, Lars W Andersen, David T Huang, Katherine M Berg, Anne V Grossestreuer, Paul E Marik, Robert L Sherwin, Peter C Hou, Lance B Becker, Michael N Cocchi and 4 more

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Critical care (London, England), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04366427 (Effects of Enriched Oxygen Mixtures and Exercise on Oxidative Stress and Stem Cells Proliferation in Athletes.), which is not on this map. Cited by 64 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed, 3 pooled it
13.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04366427 phase2completednot on this mapstarted 2020, after this paper: background citation

Effects of Enriched Oxygen Mixtures and Exercise on Oxidative Stress and Stem Cells Proliferation in Athletes.

TypeinterventionalSponsorUniversity of PadovaRan2020 to 2020Enrolled42ConditionsOxidative Stress, Stem Cell ResearchArmsL-HBO, HBO, 30% O2, 50% O2
3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 3 syntheses or guidelines pooled it, 153 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Review
  8. Article
  9. Article
  10. Copper and zinc dynamics in ovine pneumonia: a comparative analysis of treatment regimens.Veterinary research forum : an international quarterly journal · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Vitamin C and thiamine for the treatment of refractory septic shock in surgical critically ill patients: a retrospective before-and-after study.Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2023
    Article
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 10 institutions in 2 countries.

Ari MoskowitzBeth Israel Deaconess Medical Center, Department of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, Boston, MA, USA.
Lars W AndersenBeth Israel Deaconess Medical Center, Department of Emergency Medicine, Boston, MA, USA.
David T HuangDepartment of Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Katherine M BergBeth Israel Deaconess Medical Center, Department of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, Boston, MA, USA.
Anne V GrossestreuerBeth Israel Deaconess Medical Center, Department of Emergency Medicine, Boston, MA, USA.
Paul E MarikDepartment of Internal Medicine, Eastern Virginia Medical School, Norfolk, VA, USA.
Robert L SherwinDepartment of Emergency Medicine, Wayne State University School of Medicine/Detroit Receiving Hospital, Detroit, MI, USA.
Peter C HouDivision of Emergency Critical Care Medicine, Department of Emergency Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Lance B BeckerDepartment of Emergency Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA.
Michael N CocchiBeth Israel Deaconess Medical Center, Department of Emergency Medicine, Boston, MA, USA.
Pratik DoshiDepartment of Emergency Medicine and Internal Medicine, University of Texas Health Science Center at Houston, Houston, TX, USA.
Jonathan GongDonald and Barbara Zucker School of Medicine at Hofstra/Northwell, Northwell Health System, New Hyde Park, NY, USA.
Ayan SenDepartment of Critical Care Medicine, Mayo Clinic, Phoenix, AZ, USA.
Michael W DonninoBeth Israel Deaconess Medical Center, Department of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, Boston, MA, USA. mdonnino@bidmc.harvard.edu.
Beth Israel Deaconess Medical Center · USAarhus University Hospital · DKBrigham and Women's Hospital · USDetroit Receiving Hospital · USDonald & Barbara Zucker School of Medicine at Hofstra/Northwell · USEastern Virginia Medical School · USMayo Clinic Hospital · USNorthwell Health · USThe University of Texas Health Science Center at Houston · USUniversity of Pittsburgh · US

Funding

Harvard Clinical and Translational Science CenterKL2TR001100 · NCATS · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2013 to 2017
$8.5M
Acute Lung Injury Group New England Program to Support PETAL Network ResearchU01HL122989 · NHLBI · BAYSTATE MEDICAL CENTER, INC. · PI STEINGRUB, JAY S · 2014 to 2020
$2.2M
Thiamine v placebo to improve oxygen consumption after in-hospital cardiac arrestK23HL128814 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI BERG, KATHERINE M · 2016 to 2021
$1.0M
Thiamine as a Renal Protective Agent in Septic ShockK23GM128005 · NIGMS · BETH ISRAEL DEACONESS MEDICAL CENTER · PI MOSKOWITZ, ARI · 2018 to 2021
$761k
NCATS NIH HHS KL2 TR001100NHLBI NIH HHS K23 HL128814NHLBI NIH HHS U01 HL122989NIGMS NIH HHS K23 GM128005NIH HHS 1K23HL128814-01NIH HHS K23GM128005-01NIH HHS UO1HL122989-03
6 · The paper itself

Abstract

The combination of thiamine, ascorbic acid, and hydrocortisone has recently emerged as a potential adjunctive therapy to antibiotics, infectious source control, and supportive care for patients with sepsis and septic shock. In the present manuscript, we provide a comprehensive review of the pathophysiologic basis and supporting research for each element of the thiamine, ascorbic acid, and hydrocortisone drug combination in sepsis. In addition, we describe potential areas of synergy between these therapies and discuss the strengths/weaknesses of the two studies to date which have evaluated the drug combination in patients with severe infection. Finally, we describe the current state of current clinical practice as it relates to the thiamine, ascorbic acid, and hydrocortisone combination and present an overview of the randomized, placebo-controlled, multi-center Ascorbic acid, Corticosteroids, and Thiamine in Sepsis (ACTS) trial and other planned/ongoing randomized clinical trials.

Indexed as

Adrenal Cortex HormonesAnti-Bacterial AgentsAscorbic AcidDrug Therapy, CombinationHumansHydrocortisoneModels, BiologicalSepsisThiamineAdrenal Cortex HormonesAnti-Bacterial AgentsAscorbic AcidHydrocortisoneThiamineAscorbic acidCorticosteroidsMetabolic resuscitationSepsisThiamine

Identifiers

PMID30373647
PMCPMC6206928
OpenAlexW2899140988

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.